Not only venous thromboembolic events but also the sum of all side effects are decisive for
the prescription of oral contraceptives. Based on the data available today, the following …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

The risks of venous thromoembolism, myocardial infarction and ischaemic stroke are
increased in oral contraceptive users, even with oral contraceptives with≤ 35 μg of …

Introduction: Women using oral hormonal contraceptives are exposed to an increased risk of
venous thromboembolism. The incidence of venous thromboembolism in women is difficult …

Since the introduction of oral contraceptives, their use has been associated with an
increased risk of both venous and arterial thrombosis. Pulmonary embolism, myocardial …

The link between oral contraceptive usage and thromboembolic disorders has been
observed since the 1960s. Although the risks are clearly a function of the specific hormonal …

Recent studies of currently available oral contraceptives indicate that the risk of major
sequelae is low in young women (aged between 20 and 24 years). Venous …

Oral Contraceptives (OC) were introduced in the 1960s and were a major advance in family
planning technology for women. The first pills contained high doses of estrogen and …

The use of combined hormonal contraceptives (CHC) is a well-established risk factor for
venous thromboembolism (VTE). The VTE risk depends on the specific combination of …

Recent studies of current oral contraceptives indicate that the risk of cardiovascular
sequelae is low in young (age 20-24 years) reproductive-aged women. Venous …